Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…
CCS Presents Four Peer-Reviewed Posters at American Diabetes Associations 85th Scientific Sessions
CCS’s latest evidence-based research reinforces the most innovative and intelligent approaches to…
Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss…
Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology
CAESAREA, Israel, June 17, 2025 /PRNewswire/ -- A newly published, peer-reviewed study…
Llusern Scientific Announces ISO 13485 Certification for itsPoint-of-Care Diagnostics System for Urinary Tract Infections
June 17, 2025 04:00 ET Â | Source: Llusern Scientific CARDIFF, United Kingdom,…
MannKind to Highlight Data from Recent Pediatric and Adult Studiesof Inhaled Insulin (Afrezza) at American Diabetes Associations85th Scientific Sessions in Chicago, June 20-23
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 (GLOBE NEWSWIRE) --…
Mapmygenome cements global leadership in Genomics with strategic acquisition of Canada’s Microbiome Insights
HYDERABAD, India and VANCOUVER, BC, May 29, 2025 /PRNewswire/ -- Mapmygenome, an…